Pa. Cheras et al., HYPERCOAGULABILITY AND HYPOFIBRINOLYSIS IN PRIMARY OSTEOARTHRITIS, Clinical orthopaedics and related research, (334), 1997, pp. 57-67
Histologic evidence of venous thrombosis and lipid abnormalities have
previously been reported in osteoarthritis. Hypofibrinolysis has been
recorded in patients with ischemic necrosis of bone, and it has been p
roposed as a major cause of osteonecrosis. This study determines wheth
er systemic evidence of coagulation and lipid abnormalities could be d
etected in osteoarthritis. Global and specific tests were used to asse
ss coagulability and fibrinolysis in 44 patients with degenerative ost
eoarthritis of the hip and 52 matched control subjects, In patients wi
th osteoarthritis, an increase in factor VIIIc, increased platelet sen
sitivity over a range of adenosine diphosphate concentrations (0.05 mu
mol/L-4 mu mol/L) and elevated D dimer levels were found. Euglobulin
clot lysis time was prolonged in this group and plasminogen activator
inhibitor Type 1 activity was increased. Relative hyperlipidemia was o
bserved in the osteoarthritis group, with increased cholesterol, low d
ensity lipoprotein cholesterol, and triglyceride levels. It is conclud
ed that there is a hypercoagulable and prothrombotic condition in oste
oarthritis, with hypofibrinolysis and indirect evidence of increased f
ibrin generation. The possible contribution of lipid abnormalities to
hemostatic imbalance in osteoarthritis is discussed.